Related Experiment Video
Updated: Nov 15, 2025

07:42
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.4K
Plasma Tumor Mutation Burden and Response to Pembrolizumab-Letter
Zhiqiang Xue1, Xueguang Guo2, Jiaxin Wen3
1Department of Thoracic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, P.R. China. xuezhiqiang301@126.com.
Abstract
No abstract available in PubMed .

